Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor ##### Up next ![CANEUS & Government of Maharashtra Announce Partnership at WEF Davos](https://i0.wp.com/mma.prnasia.com/media2/2868018/Caneus_International_Partnership.jpg?resize=200%2C110&ssl=1 "CANEUS & Government of Maharashtra Announce Partnership at WEF Davos") [](https://thailandbusinessnews.net/press-release/caneus-government-of-maharashtra-announce-partnership-at-wef-davos/) ###### [CANEUS & Government of Maharashtra Announce Partnership at WEF Davos](https://thailandbusinessnews.net/press-release/caneus-government-of-maharashtra-announce-partnership-at-wef-davos/) Published on 23 January 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study in the United States. The Phase I clinical trial aims to evaluate safety, tolerability, and pharmacokinetics profiles. ISM8969 is a novel oral therapeutic candidate developed through Insilico’s Pharma.AI, with best-in-class potential, unique brain penetrant traits, and favorable druggability profiles demonstrated in preclinical studies. Insilico Medicine has entered into a co-development collaboration agreement with Hygtia Therapeutics, with both parties each holding 50% of the global rights and interests to the program. In return, Insilico is eligible to receive up to $66 million in upfront and milestone payments. CAMBRIDGE, Mass., Jan. 23, 2026 /PRNewswire/ — Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has recently received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA), intended for the treatment of Parkinson’s Disease. The Phase I clinical trial plans to evaluate the safety, tolerability, and pharmacokinetics of ISM8969 in healthy volunteers, and to identify the optimal dose level(s) to be recommended for further investigation. "NLRP3 has emerged as a key contributor to chronic neuroinflammation and disease progression in neurodegenerative disorders. A novel NLRP3 inhibitor, ISM8969 with the desired brain penetrant property made possible via our AI-powered design process, offers the potential to advance Parkinson’s Disease treatment to the next generation," says Carol Satler, MD, PhD, Senior Vice President for Clinical Development, Non-Oncology, Insilico Medicine. "We are excited to get the greenlight from FDA to advance this novel therapeutic to human clinical trials, and we hope to induce a genuine paradigm shift with AI breakthrough in novel drug discovery." Excessive activation of NLRP3 triggers overproduction of pro-inflammatory cytokines and chemokines, resulting in sustained inflammation and tissue damage. By inhibiting NLRP3, ISM8969 aims to modulate this pathological inflammation, supporting neuronal survival and function among patients with neurodegenerative diseases. In December 2024, ISM8969 was nominated as an orally administered, potential best-in-class preclinical candidate targeting NLRP3. It is worth noting that ISM8969 was discovered and optimized using Insilico’s Chemistry42, the comprehensive generative chemistry engine consisting of multiple applications across the drug design and discovery stages. More importantly, with the ability to cross the blood-brain barrier and reach the central nervous system (CNS) directly, ISM8969 establishes its distinctive advantage against CNS disorders including Parkinson’s Disease, apart from a balanced druggability profile and efficacy against inflammation in both inflammatory and chronic disease mice models. To accelerate the global development of ISM8969, Insilico Medicine has entered into a co-development collaboration agreement with Hygtia Therapeutics. Under the agreement, Insilico grants Hygtia Therapeutics worldwide rights to research, develop, register, manufacture, and commercialize ISM8969, with both parties each holding 50% of the global rights and interests to the program. In return, Insilico is eligible to receive up to $66 million in upfront and milestone payments. Based on its comprehensive portfolio empowered by Pharma.AI, Insilico has achieved dozens of collaborations with global leading pharma companies including Sanofi, Lilly, Exelixis and Menarini, and the three key license-out deals sum up to a maximum total contract value of up to US $2.1 billion. Harnessing state-of-the-art AI and automation technologies, Insilico has significantly improved the efficiency of preclinical drug development, setting a[ benchmark](https://www.eurekalert.org/news-releases/1073344) for AI-driven drug R&D. While traditional early-stage drug discovery typically requires an average of 4.5 years, Insilico has nominated 20 preclinical candidates from 2021 to 2024, with an average timeline—from project initiation to preclinical candidate (PCC) nomination—of just 12 to 18 months per program, with only 60 to 200 molecules synthesized and tested in each program. About Insilico Medicine Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend healthy longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.HK. By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma.AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine. For more information, please visit[ www.insilico.com](http://www.insilico.com/) [Source link ](http://www.prnasia.com/story/archive/4869099_CN69099_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/gkgd-unveils-new-led-display-portfolio-for-diverse-applications-at-ise-2026/) ## GKGD Unveils New LED Display Portfolio for Diverse Applications at ISE 2026 BARCELONA, Spain and CHANGZHI, China, Jan. 23, 2026 /PRNewswire/ — GKGD, a leading… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - January 23, 2026 [](https://thailandbusinessnews.net/press-release/maxhub-strengthens-commitment-to-sustainability-with-ungc-principles-integration-in-global-operations/) ![MAXHUB Strengthens Commitment to Sustainability with UNGC Principles Integration in Global Operations](https://i0.wp.com/r2.thailandbusinessnews.net/2025/02/MAXHUB_Logo.jpg?resize=260%2C87&ssl=1 "MAXHUB Strengthens Commitment to Sustainability with UNGC Principles Integration in Global Operations") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## MAXHUB Strengthens Commitment to Sustainability with UNGC Principles Integration in Global Operations GUANGZHOU, China, Feb. 17, 2025 /PRNewswire/ — As a proud supporter of the… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - February 17, 2025 [](https://thailandbusinessnews.net/press-release/antler-maintains-strong-momentum-in-vietnam-making-40-investments-over-past-two-years-despite-market-headwinds/) ## Antler Maintains Strong Momentum in Vietnam, Making 40 Investments Over Past Two Years Despite Market Headwinds [Cover image here] HO CHI MINH, Vietnam, Jan. 21, 2025 /PRNewswire/ —… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - January 21, 2025 ##### Most Read - [![NYSE Honors Victims of 9/11: NYSE Content Update](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/nyse-honors-victims-of-9-11-nyse-content-update/ "NYSE Honors Victims of 9/11: NYSE Content Update") [NYSE Honors Victims of 9/11: NYSE Content Update](https://thailandbusinessnews.net/press-release/nyse-honors-victims-of-9-11-nyse-content-update/ "NYSE Honors Victims of 9/11: NYSE Content Update") - [![LOTTE HOTELS & RESORTS Launches Exclusive Travel Pass Featuring Limited-Edition Korean Heritage Transit Cards](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/lotte-hotels-resorts-launches-exclusive-travel-pass-featuring-limited-edition-korean-heritage-transit-cards/ "LOTTE HOTELS & RESORTS Launches Exclusive Travel Pass Featuring Limited-Edition Korean Heritage Transit Cards") [LOTTE HOTELS & RESORTS Launches Exclusive Travel Pass Featuring Limited-Edition Korean Heritage Transit Cards](https://thailandbusinessnews.net/press-release/lotte-hotels-resorts-launches-exclusive-travel-pass-featuring-limited-edition-korean-heritage-transit-cards/ "LOTTE HOTELS & RESORTS Launches Exclusive Travel Pass Featuring Limited-Edition Korean Heritage Transit Cards") - [![Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/vitafoods-asia-announces-strategic-move-to-kuala-lumpur-for-2027-edition/ "Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition") [Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition](https://thailandbusinessnews.net/press-release/vitafoods-asia-announces-strategic-move-to-kuala-lumpur-for-2027-edition/ "Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition") - [![Meritz Securities Connects to Bruce Markets' Data Feed for U.S. Equities, Improving Market Data for Korean Traders](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/meritz-securities-connects-to-bruce-markets-data-feed-for-u-s-equities-improving-market-data-for-korean-traders/ "Meritz Securities Connects to Bruce Markets' Data Feed for U.S. Equities, Improving Market Data for Korean Traders") [Meritz Securities Connects to Bruce Markets' Data Feed for U.S. Equities, Improving Market Data for Korean Traders](https://thailandbusinessnews.net/press-release/meritz-securities-connects-to-bruce-markets-data-feed-for-u-s-equities-improving-market-data-for-korean-traders/ "Meritz Securities Connects to Bruce Markets' Data Feed for U.S. Equities, Improving Market Data for Korean Traders") - [![DITP Approves Six Initiatives to Propel Thai Y-Series Content into Global Markets in 2026](https://i0.wp.com/r2.thailandbusinessnews.net/2026/03/DITP-Approves-Six-Initiatives-to-Propel-Thai-Y-Series-Content-into.webp.webp?fit=1200%2C851&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/business/ditp-approves-six-initiatives-to-propel-thai-y-series-content-into-global-markets-in-2026/ "DITP Approves Six Initiatives to Propel Thai Y-Series Content into Global Markets in 2026") [DITP Approves Six Initiatives to Propel Thai Y-Series Content into Global Markets in 2026](https://thailandbusinessnews.net/business/ditp-approves-six-initiatives-to-propel-thai-y-series-content-into-global-markets-in-2026/ "DITP Approves Six Initiatives to Propel Thai Y-Series Content into Global Markets in 2026") - [![XTransfer Debuts at Seamless Africa 2026 Reinforcing Commitment to Africa's SME Trade](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/xtransfer-debuts-at-seamless-africa-2026-reinforcing-commitment-to-africas-sme-trade/ "XTransfer Debuts at Seamless Africa 2026 Reinforcing Commitment to Africa's SME Trade") [XTransfer Debuts at Seamless Africa 2026 Reinforcing Commitment to Africa's SME Trade](https://thailandbusinessnews.net/press-release/xtransfer-debuts-at-seamless-africa-2026-reinforcing-commitment-to-africas-sme-trade/ "XTransfer Debuts at Seamless Africa 2026 Reinforcing Commitment to Africa's SME Trade") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/sullivan-cromwell-opens-office-in-adgm/) ## Sullivan & Cromwell Opens Office in ADGM Ahmed T. el-Gaili Rejoins as a Partner to Lead the Firm’s Expansion… [](https://thailandbusinessnews.net/press-release/gac-commercial-vehicle-accelerates-global-expansion-with-iaa-transportation-2026-debut/) ![GAC Commercial Vehicle Accelerates Global Expansion with IAA TRANSPORTATION 2026 Debut](https://i0.wp.com/mmx.prnasia.com/media/MS1987616/20260914115951EDT_image_1.jpg?resize=260%2C140&ssl=1 "GAC Commercial Vehicle Accelerates Global Expansion with IAA TRANSPORTATION 2026 Debut") ## GAC Commercial Vehicle Accelerates Global Expansion with IAA TRANSPORTATION 2026 Debut HANNOVER, Germany, Sept. 15, 2026 /PRNewswire/ — GAC Commercial Vehicle debuted… [](https://thailandbusinessnews.net/press-release/foton-showcases-its-full-product-portfolio-in-hannover-advancing-a-new-model-for-the-global-expansion-of-chinas-commercial-vehicle-value-chain/) ![FOTON Showcases Its Full Product Portfolio in Hannover, Advancing a New Model for the Global Expansion of China's Commercial Vehicle Value Chain](https://i0.wp.com/mmx.prnasia.com/media/MS1987630/20260914120913EDT_image_3.jpg?resize=260%2C140&ssl=1 "FOTON Showcases Its Full Product Portfolio in Hannover, Advancing a New Model for the Global Expansion of China's Commercial Vehicle Value Chain") ## FOTON Showcases Its Full Product Portfolio in Hannover, Advancing a New Model for the Global Expansion of China's Commercial Vehicle Value Chain BEIJING, Sept. 15, 2026 /PRNewswire/ — On September 14, IAA TRANSPORTATION… [](https://thailandbusinessnews.net/press-release/momcozy-launches-mom-and-more-celebrating-the-expansive-journey-of-motherhood/) ![Momcozy Launches "Mom, and More," Celebrating the Expansive Journey of Motherhood](https://i0.wp.com/mmx.prnasia.com/media/MS1987151/20260913230131EDT_image_1.jpg?resize=260%2C140&ssl=1 "Momcozy Launches "Mom, and More," Celebrating the Expansive Journey of Motherhood") ## Momcozy Launches "Mom, and More," Celebrating the Expansive Journey of Motherhood Allyson Felix, Kellie Gerardi and Reshma Saujani join Momcozy to share stories…